England’s NICE recommends FILSPARI as a treatment option for IgA nephropathy Read More » May 23, 2025
Emvenio Research Exceeds Diversity Goals For Metabolic Disease Clinical Trial Read More » May 15, 2025
AO Foundation Selects Trial Interactive to Digitize Clinical Trial Operations Read More » May 14, 2025
